当前位置:首页 - 行情中心 - 云南白药(000538) - 财务分析 - 现金流量表

云南白药

(000538)

  

流通市值:980.77亿  总市值:987.23亿
流通股本:17.73亿   总股本:17.84亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金40,638,627,018.4929,925,903,156.6320,702,033,007.459,660,075,673.88
收到的税费返还4,858,426.215,075,725.594,075,145.253,597,589.32
收到其他与经营活动有关的现金689,121,507.54474,012,168.96243,193,845.25114,960,122
经营活动现金流入的平衡项目0000
经营活动现金流入小计41,332,606,952.2430,404,991,051.1820,949,301,997.959,778,633,385.2
购买商品、接受劳务支付的现金29,797,492,545.6522,133,038,536.2314,862,338,495.137,192,674,623.82
支付给职工以及为职工支付的现金2,585,937,678.631,827,770,823.051,247,729,927.92651,300,998.76
支付的各项税费2,465,312,635.541,895,562,214.361,315,371,659.24517,357,815.32
支付其他与经营活动有关的现金2,981,121,744.41,959,033,000.431,271,910,545.56683,555,744.84
经营活动现金流出的平衡项目0000
经营活动现金流出小计37,829,864,604.2227,815,404,574.0718,697,350,627.859,044,889,182.74
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额3,502,742,348.022,589,586,477.112,251,951,370.1733,744,202.46
二、投资活动产生的现金流量:
收回投资收到的现金2,558,487,934.52,408,096,867.72968,704,891.05549,327,186.64
取得投资收益收到的现金436,150,493.91428,497,195.0516,545,231.65,137,668.34
处置固定资产、无形资产和其他长期资产收回的现金净额282,170.75197,342172,44010,000
收到的其他与投资活动有关的现金1,978,176,523.1465,645,353.13363,000,0003,000,000
投资活动现金流入的平衡项目0000
投资活动现金流入小计4,973,097,122.263,302,436,757.91,348,422,562.65557,474,854.98
购建固定资产、无形资产和其他长期资产支付的现金575,507,137.9389,382,386.28275,314,995.16135,987,618.23
投资支付的现金73,700,00073,700,00068,700,000639,802,094.67
支付其他与投资活动有关的现金3,805,309,321.722,305,272,300697,318,80097,318,800
投资活动现金流出的平衡项目0000
投资活动现金流出小计4,454,516,459.622,768,354,686.281,041,333,795.16873,108,512.9
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额518,580,662.64534,082,071.62307,088,767.49-315,633,657.92
三、筹资活动产生的现金流量:
吸收投资收到的现金2,670,0002,670,000--
其中:子公司吸收少数股东投资收到的现金2,670,0002,670,000--
取得借款收到的现金1,376,188,273.49901,453,995.03592,248,791.91235,590,426.42
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,378,858,273.49904,123,995.03592,248,791.91235,590,426.42
偿还债务支付的现金1,424,233,267.771,208,474,903.38917,334,047.3382,032,321.17
分配股利、利润或偿付利息支付的现金2,767,483,369.052,757,260,303.342,741,240,399.439,364,159.78
其中:子公司支付给少数股东的股利、利润19,857,165.9619,857,165.9611,316,213.63-
支付其他与筹资活动有关的现金105,183,876.2669,527,344.0741,375,308.912,916,955.56
筹资活动现金流出平衡项目0000
筹资活动现金流出小计4,296,900,513.084,035,262,550.793,699,949,755.66104,313,436.51
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-2,918,042,239.59-3,131,138,555.76-3,107,700,963.75131,276,989.91
四、汇率变动对现金及现金等价物的影响2,324,684.955,005,521.315,239,164.08-5,255,965.79
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额1,105,605,456.02-2,464,485.72-543,421,662.08544,131,568.66
加:期初现金及现金等价物余额13,046,160,012.4713,046,160,012.4713,046,160,012.4713,046,160,012.47
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额14,151,765,468.4913,043,695,526.7512,502,738,350.3913,590,291,581.13
补充资料:
净利润4,122,561,096.49-2,826,258,821.44-
资产减值准备194,582,766.59-55,672,247.39-
固定资产和投资性房地产折旧208,456,263.24-105,698,740.66-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧208,456,263.24-105,698,740.66-
无形资产摊销30,940,993.27-15,220,430.41-
长期待摊费用摊销33,493,659.88-14,699,584.4-
处置固定资产、无形资产和其他长期资产的损失79,370.88--5,403,078.51-
固定资产报废损失10,575,067.5-2,435,656.06-
公允价值变动损失-123,566,330.46--53,088,928.07-
财务费用49,601,252.93-18,798,896.05-
投资损失-779,010,728.82--421,542,165.56-
递延所得税-929,594.85-7,720,302.64-
其中:递延所得税资产减少22,377,570.54-36,123,144.16-
递延所得税负债增加-23,307,165.39--28,402,841.52-
存货的减少1,539,521,695.37-1,078,680,567.88-
经营性应收项目的减少-2,088,116,474.45--274,823,081.61-
经营性应付项目的增加198,990,559.88--1,172,171,057.16-
其他5,257,571.82---
现金的期末余额14,151,765,468.49-12,502,738,350.39-
减:现金的期初余额13,046,160,012.47-13,046,160,012.47-
公告日期2024-03-302023-10-312023-08-302023-04-27
审计意见(境内)标准无保留意见
TOP↑